Search

Your search keyword '"Muhammet Dural"' showing total 2 results
Start Over Author "Muhammet Dural" Journal biomarkers in medicine
2 results on '"Muhammet Dural"'

1. Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19

Author

Selda Murat, Bektas Murat, Gurbet Özge Mert, Muhammet Dural, and Yuksel Cavusoglu

Subjects
Male, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), medicine.medical_treatment, Clinical Biochemistry, Fibrinogen, Fibrin Fibrinogen Degradation Products, Internal medicine, Drug Discovery, D-dimer, Medicine, Humans, Aged, Retrospective Studies, Mechanical ventilation, Aged, 80 and over, Heart Failure, business.industry, SARS-CoV-2, Cardiogenic shock, Biochemistry (medical), COVID-19, Retrospective cohort study, D-dimer/fibrinogen ratio, Middle Aged, medicine.disease, Prognosis, Hospital outcomes, coronavirus disease, Heart failure, Cardiology, Female, business, Biomarkers, medicine.drug, Research Article
Abstract

Aim: In the present study, the relationship between D-dimer/fibrinogen ratio (DFR) and in-hospital outcomes was evaluated in patients with COVID-19 and a diagnosis of heart failure (HF). Materials & methods: In-hospital outcomes were compared in patients with high and low DFR values. Results: With regard to in-hospital outcomes, patients in the third tertile of DFR had a higher rate of mechanical ventilation, cardiogenic shock and death (p

Published
2021

2. Relationship between serum bilirubin levels and presence of fragmented QRS in patients with acute coronary syndrome

Author

Hüdaverdi Hocamguliyev, Murat Tulmaç, Sadik Acikel, Engin Algül, Tolga Çimen, Hamza Sunman, Muhammet Dural, and Haluk Furkan Şahan

Subjects
Male, medicine.medical_specialty, Acute coronary syndrome, Turkey, Bilirubin, medicine.medical_treatment, Clinical Biochemistry, 030204 cardiovascular system & hematology, Electrocardiography, Ventricular Dysfunction, Left, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Liver Function Tests, Internal medicine, Drug Discovery, medicine, Humans, ST segment, 030212 general & internal medicine, Acute Coronary Syndrome, Aged, Hematologic Tests, Ejection fraction, medicine.diagnostic_test, biology, business.industry, Biochemistry (medical), Percutaneous coronary intervention, Stroke Volume, Middle Aged, Prognosis, medicine.disease, Troponin, Survival Rate, Cross-Sectional Studies, chemistry, Case-Control Studies, Cardiology, biology.protein, Female, business, Liver function tests, Biomarkers, Follow-Up Studies
Abstract

Aim: To assess the relationship between serum bilirubin levels and fragmented QRS (fQRS), and their association with adverse events in patients with acute coronary syndrome. Methods: This study included a total of 736 patients. Laboratory results such as bilirubin levels, renal and liver function tests were obtained from the first available blood sample. Results: Left ventricular ejection fraction, end-diastolic diameter and total bilirubin level were significantly lower in fQRS (+) group than in the control group (45.0 [40.0–55.0] vs 50.0 [45.0–60.0]%; p < 0.001; 4.7 [4.6–5.1] vs 4.7 [4.5–4.9] cm; p < 0.001; 0.66 [0.49–5.1] vs 0.72 [0.53–0.97] md/dl; p = 0.017); respectively. Occurrence of adverse events was significantly higher in fQRS (+) group (32.5 vs 20.5 %; p = 0.013) during mean 1-year follow-up period. Conclusion: Total bilirubin level is an independent predictor of fQRS formation, which is associated with the presence of adverse events in patients with acute coronary syndrome.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results